These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1471425)

  • 1. Pertussis: the trials and tribulations of old and new pertussis vaccines.
    Cherry JD
    Vaccine; 1992; 10(14):1033-8. PubMed ID: 1471425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
    N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 112-Year Odyssey of Pertussis and Pertussis Vaccines-Mistakes Made and Implications for the Future.
    Cherry JD
    J Pediatric Infect Dis Soc; 2019 Sep; 8(4):334-341. PubMed ID: 30793754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
    Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
    N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Historical review of pertussis and the classical vaccine.
    Cherry JD
    J Infect Dis; 1996 Nov; 174 Suppl 3():S259-63. PubMed ID: 8896526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Mar; 46(RR-7):1-25. PubMed ID: 9091780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Licensed pertussis vaccines in the United States. History and current state.
    Klein NP
    Hum Vaccin Immunother; 2014; 10(9):2684-90. PubMed ID: 25483496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress towards the development of new vaccines against whooping cough.
    Rappuoli R; Podda A; Pizza M; Covacci A; Bartoloni A; de Magistris MT; Nencioni L
    Vaccine; 1992; 10(14):1027-32. PubMed ID: 1471424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pertussis vaccine trials in the 1990s.
    Lambert LC
    J Infect Dis; 2014 Apr; 209 Suppl 1(Suppl 1):S4-9. PubMed ID: 24626871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acellular pertussis vaccines--a solution to the pertussis problem.
    Cherry JD
    J Infect Dis; 1993 Jul; 168(1):21-4. PubMed ID: 8515111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
    J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
    Hegerle N; Guiso N
    Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acellular pertussis vaccines].
    Finger H; Wirsing von König CH
    Immun Infekt; 1992 Dec; 20(6):188-91. PubMed ID: 1490723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of acellular pertussis vaccines].
    Wirsing von König CH; Finger H
    Immun Infekt; 1995 Aug; 23(4):125-9. PubMed ID: 7558115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
    Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
    Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis vaccines: present status.
    Christodoulides M
    Adv Biotechnol Processes; 1990; 13():169-99. PubMed ID: 2185783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of pertussis: An unresolved problem.
    Esposito S; Principi N
    Hum Vaccin Immunother; 2018; 14(10):2452-2459. PubMed ID: 29856680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acellular pertussis vaccines in adults.
    Keitel WA; Edwards KM
    Infect Dis Clin North Am; 1999 Mar; 13(1):83-94, vi. PubMed ID: 10198793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis: persistent pathogen, imperfect vaccines.
    Yeh SH
    Expert Rev Vaccines; 2003 Feb; 2(1):113-27. PubMed ID: 12901603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.